131I tositumomab -: A viewpoint by Wolfgang!Kern

被引：1
|
作者：
Kern, W [1 ]
机构：
[1] Univ Munich, Hosp Grosshadern, Dept Internal Med 3, Munich, Germany
来源：
BIODRUGS | 2000年 / 14卷 / 03期
关键词：
D O I：
10.2165/00063030-200014030-00006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [1] 131I TositumomabA Viewpoint by Wolfgang Kern
    Wolfgang Kern
    BioDrugs, 2000, 14 : 203 - 203
  • [2] 131I tositumomab -: A viewpoint by Michael L!Grossbard
    Grossbard, ML
    BIODRUGS, 2000, 14 (03) : 203 - 204
  • [3] 131I tositumomab
    Culy, CR
    Lamb, HM
    BIODRUGS, 2000, 14 (03) : 195 - 202
  • [4] 131I Tositumomab
    Christine R. Culy
    Harriet M. Lamb
    BioDrugs, 2000, 14 : 195 - 202
  • [5] Tositumomab and iodine [131I] tositumomab in the management of follicular lymphoma -: An onocologist's view
    Davies, AJ
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 48 (04): : 305 - 316
  • [6] Long-term follow-up of patients treated with tositumomab and 131I tositumomab (BEXXAR™)
    Davies, A. J.
    Radford, J. A.
    Rohatiner, A. Z.
    Linton, K. M.
    Matthews, J.
    Johnson, P. W.
    Lister, T. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 181 - 181
  • [7] Tositumomab and 131I therapy in non-Hodgkin's lymphoma
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 : 128S - 140S
  • [8] Tositumomab and Iodine I 131 Tositumomab (Bexaar)
    Srinivasan, A.
    Mukherji, S. K.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (04) : 637 - 638
  • [9] I-131 tositumomab
    William, Basem M.
    Bierman, Philip J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (08) : 1271 - 1278
  • [10] 131I TositumomabA Viewpoint by Michael L. Grossbard
    Michael L. Grossbard
    BioDrugs, 2000, 14 : 203 - 204
12345